Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Pharmacokinetics of Cytochrome P450: Influence on the Pharmacokinetics of Naproxen (CYP2C8 and CYP2C9) and Associated Naproxen-esomeprazole (CYP2C19)

NCT03092193 is registered in ClinicalTrials.gov with University of Sao Paulo as lead sponsor.

NCT NCT03092193
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03092193 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Pharmacokinetics of Cytochrome P450: Influence on the Pharmacokinetics of Naproxen (CYP2C8 and CYP2C9) and Associated Naproxen-esomeprazole (CYP2C19)
Lead sponsor
University of Sao Paulo
Phase
Phase 4
Overall status
Completed
Start date
March 1, 2017
Completion date
October 1, 2017
Enrollment
8 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

poor metabolizer due to cytochrome p450 cyp2c19 variant, poor metabolizer due to cytochrome p450 cyp2c9 variant